Related Experiment Video
Updated: Feb 21, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Midazolam prevents motor neuronal death from oxidative stress attack mediated by JNK-ERK pathway
Guo-Zheng Li1, Hong-Lei Tao1, Cheng Zhou1
1Department of Anesthesiology, Tongde Hospital of Zhejiang Province, 234 Gucui Road, Hangzhou, 310012, Zhejiang, China.
Abstract:
Midazolam is a sedative used by patients with mechanical ventilation. However, the potential clinical value is not fully explored. In this report, we made use of a neuroblastoma-spinal cord hybrid motor neuron-like cell line NSC34, and elucidated the potential role of Midazolam on these cells under the insult of oxidative stress. We found the protective effect of Midazolam on motor neurons against cytotoxicity induced by the combination of oligomycin A and rotenone (O/R) or phenylarsine oxide. The characteristics of apoptosis, such as the ratio of TUNEL+ cells or the expression level of cleaved Caspase-3, was decreased by 22 or 45% in the presence of Midazolam. Furthermore, this effect was correlated with the JNK-ERK signaling pathway. Either phosphorylation of ERK or JNK was positively or negatively modulated with the treatment of Midazolam in NSC34 cells attacked by reactive oxygen species. Meanwhile, inhibition or activation of the JNK-ERK pathway regulated the protective effect of Midazolam on NSC34 cells with oxidative stress insult. Collectively, this study elucidated a previously unidentified clinical effect of Midazolam, and put forward the great promise that Midazolam may be considered as a potential candidate to the treatment of motor neuron disease.
Insights
Midazolam protects motor neurons from oxidative stress by reducing apoptosis. This sedative may be a promising treatment for motor neuron diseases by modulating the JNK-ERK signaling pathway.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Midazolam is a sedative commonly used in mechanical ventilation.
- Its neuroprotective potential, particularly against oxidative stress, remains underexplored.
- Motor neuron diseases are characterized by the degeneration of motor neurons.
Purpose of the Study:
- To investigate the protective effects of Midazolam on motor neuron-like cells (NSC34) under oxidative stress.
- To elucidate the role of the JNK-ERK signaling pathway in Midazolam's neuroprotective mechanism.
- To assess Midazolam's potential as a therapeutic agent for motor neuron diseases.
Main Methods:
- Utilized the NSC34 cell line, a hybrid motor neuron-like cell model.
- Induced oxidative stress using oligomycin A and rotenone (O/R) or phenylarsine oxide.
- Assessed apoptosis via TUNEL assay and cleaved Caspase-3 expression.
- Analyzed the modulation of the JNK-ERK signaling pathway, including phosphorylation levels.
Main Results:
- Midazolam demonstrated a significant protective effect against oxidative stress-induced cytotoxicity in NSC34 cells.
- Apoptosis markers, including TUNEL+ cells and cleaved Caspase-3, were reduced by 22% and 45%, respectively.
- Midazolam modulated the phosphorylation of JNK and ERK signaling pathways, influencing cell survival under oxidative stress.
Conclusions:
- Midazolam exhibits previously unrecognized neuroprotective properties against oxidative stress in motor neuron-like cells.
- The protective effects are mediated, in part, through the modulation of the JNK-ERK signaling pathway.
- Midazolam shows promise as a potential therapeutic candidate for treating motor neuron diseases.
Related Concept Videos
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

